Status:

COMPLETED

Assessing Health Electronically for Adolescent and Young Adult Oncology

Lead Sponsor:

Seattle Children's Hospital

Collaborating Sponsors:

Tickit Health Solutions

Conditions:

Risk Reduction Behavior

Eligibility:

All Genders

13-29 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to modify an existing Seattle Children's Hospital investigator-developed, patient-centered, electronic health assessment (eHA) called "Check Yourself" for AYAs with cancer...

Detailed Description

Unmet needs among Adolescents and Young Adults (AYAs) with cancer translate to poor physical and psychosocial outcomes. This is particularly true when it comes to AYA sexual health. Our team has found...

Eligibility Criteria

Inclusion

  • Eligible adolescents and young adults will be 13 to 29 years old, have an oncologic diagnosis for which they are receiving cancer directed therapy, have an appointment to see an SCH oncology provider and will be able to understand English.
  • Eligible oncology providers will either be a Physician (Fellow or Attending) or Advance Practice Provider (Nurse Practitioner or Physicians Assistant), have an appointment to see an adolescent or young adult receiving cancer directed therapy receiving who is also enrolled on the study.

Exclusion

  • Participants will be excluded from the study if they do not meet age requirements, do not have an appointment in oncology clinic, lack the means to complete follow-up interviews (i.e., has neither telephone nor internet access), and/or are not able to understand English. Our experience in the Seattle region is that, because of English Language Learning schooling supports, inability to read or understand English is a barrier for \<0.5% of adolescents. Thus, we do not anticipate that language restrictions will significantly limit the demographic distribution of our participants.

Key Trial Info

Start Date :

April 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2023

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04484194

Start Date

April 15 2021

End Date

March 31 2023

Last Update

April 12 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seattle Children's

Seattle, Washington, United States, 98105